Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Intervalo de año de publicación
1.
Medicina (B Aires) ; 56(3): 299-307, 1996.
Artículo en Español | MEDLINE | ID: mdl-9035489

RESUMEN

Prevention of venous thromboembolism (VTE) can be achieved through mechanic or pharmacological means. For the latter, unfractionated low dose heparin, low molecular weight heparins and oral anticoagulants are successfully and widely employed. Results of controlled and uncontrolled studies favour the use of prophylactic heparin in different clinical and surgical conditions such as myocardial infarction, stroke, orthopedic or prolonged surgery and surgical interventions in patients older than forty. Useful parameters to evaluate the results of VTE prophylaxis are discussed as well as timing, duration, effectiveness, side effects and costs of therapy. Although the benefits of VTE prophylaxis in high risk patients are clear, it is not routinely employed in Argentina.


Asunto(s)
Tromboembolia/prevención & control , Anticoagulantes/uso terapéutico , Vendajes , Análisis Costo-Beneficio , Dihidroergotamina/uso terapéutico , Heparina/uso terapéutico , Heparina de Bajo-Peso-Molecular/administración & dosificación , Heparina de Bajo-Peso-Molecular/uso terapéutico , Humanos , Cuidados Preoperatorios , Embolia Pulmonar/epidemiología , Factores de Riesgo , Tromboembolia/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA